MedTrace Logo

Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes

NCT02970357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-11-20

No results posted yet for this study

Summary

The needs of children and teens with type 1 diabetes are very specific and different from the adults with type 1 diabetes. Many organizations such as the World Health Organization or the International Society for Pediatric and Adolescent Diabetes, recommend a patient therapeutic education when it comes to children with type 1 diabetes.

This study aims to evaluate the impact of a therapeutic education program on theoretical knowledge of the disease and also on quality of life, on biological and clinical indicators.

Conditions

  • Diabetes Mellitus, Type I
  • Program Evaluation
  • Therapeutic Education
  • Children

Interventions

OTHER

DIAPASON Questionnaire

50 item questionnaire of the French Youth Diabetes Association to evaluate one's theoretical knowledge about the diabetes disease. 6 main themes are evaluated : * what is diabetes * Monitoring * Hypoglycemia and Hyperglycemia * Nutrition * Insuline

BEHAVIORAL

WHO-5

5 item questionnaire of the World Health Organization about quality of life

Sponsors & Collaborators

  • Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

    lead OTHER

Principal Investigators

  • Fatiha GUEMAZI-KHEFFI, MD · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-26
Primary Completion
2017-03-20
Completion
2017-03-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02970357 on ClinicalTrials.gov